Related Experiment Video
Updated: Jun 8, 2025
06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
139
[Prostate cancer screening : to be recommended in 2024?]
Alexandrine Bosshart1, Frédéric Bacchetta2, Anne Boesch3
1Unisanté, Centre universitaire de médecine générale et santé publique, 1011 Lausanne.
Revue Medicale Suisse
|November 7, 2024
Summary
The Prostate Specific Antigen (PSA) blood test screens for prostate cancer in men aged 50-69. Using multiparametric MRI after a positive PSA can reduce biopsies and overdiagnosis risks.
Area of Science:
- Oncology
- Diagnostic Imaging
- Urology
Context:
- Prostate Specific Antigen (PSA) blood test is the sole screening method for prostate cancer.
- Screening is advised for men aged 50-69 within a shared decision-making framework.
- Overdiagnosis presents a significant risk associated with PSA screening.
Purpose:
- To outline the current recommendations and risks associated with Prostate Specific Antigen (PSA) screening.
- To explore strategies for mitigating the risks of overdiagnosis in prostate cancer screening.
- To highlight the role of advanced imaging in refining diagnostic pathways.
Summary:
- The Prostate Specific Antigen (PSA) test is the primary tool for prostate cancer screening, recommended for men aged 50-69.
- Screening decisions should involve patient-doctor consultation using decision aids due to overdiagnosis risks.
- Screening frequency is individualized based on risk factors, age, and family history.
- Multiparametric MRI (mpMRI) post-PSA test can decrease unnecessary biopsies, thereby reducing overdiagnosis.
Impact:
- Informed patient-doctor decision-making for prostate cancer screening.
- Potential reduction in unnecessary invasive procedures like biopsies.
- Improved accuracy and specificity in prostate cancer diagnosis.
- Mitigation of the harms associated with prostate cancer overdiagnosis and overtreatment.
Related Concept Videos
01:20Disorders of the Male Reproductive System
338
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
338
01:30Cancer Vaccines
341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341